1887

Abstract

The human placenta is relatively resistant to (HIV-1), but obstetric complications associated with inflammatory processes, including chorioamnionitis and spontaneous preterm delivery, are associated with increased rates of vertical transmission. It was hypothesized that the pro-inflammatory mediator tumour necrosis factor alpha (TNF-), which promotes HIV-1 transmission across endothelial membranes, increases HIV-1 transmission across the placenta. Flow cytometry and immunostaining studies were performed, which demonstrated that the HIV-1 receptors CD4, CCR5 and CXCR4 were not expressed by villous trophoblast cells. Consequently, primary villous trophoblast cells were not infected with cell-free HIV-1 isolates, as measured by PCR and quantitative PCR, but villous trophoblast cells were infected by HIV-1-infected peripheral blood mononuclear cells (PBMC). HIV-1 from infected PBMC was rapidly transported across confluent transformed trophoblast cell monolayers by transcytosis, and TNF- significantly upregulated transcytosis of HIV-1 across the trophoblast layer without disrupting cell viability or confluency. Inhibitors of TNF- (antibodies against TNF- and TNF- receptors) and an anti-inflammatory drug (tenidap) significantly reduced transcytosis rates. It was concluded that the villous trophoblast is resistant to infection by cell-free HIV-1 but susceptible to transcytosis of HIV-1 from infected PBMC, and inflammatory mediators such as TNF- may play a critical role in promoting maternal–fetal transmission of HIV-1.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81071-0
2006-08-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/8/2269.html?itemId=/content/journal/jgv/10.1099/vir.0.81071-0&mimeType=html&fmt=ahah

References

  1. Anderson, V. M. ( 1997; ). The placental barrier to maternal HIV infection. Obstet Gynecol Clin North Am 24, 797–820.[CrossRef]
    [Google Scholar]
  2. Arechavaleta-Velasco, F., Marciano, D., Diaz-Cueto, L. & Parry, S. ( 2004; ). Matrix metalloproteinase-8 is expressed in human chorion during labor. Am J Obstet Gynecol 190, 843–850.[CrossRef]
    [Google Scholar]
  3. Bertolli, J., St Louis, M. E., Simonds, R. J., Nieburg, P., Kamenga, M., Brown, C., Tarande, M., Quinn, T. & Ou, C. Y. ( 1996; ). Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis 174, 722–726.[CrossRef]
    [Google Scholar]
  4. Bomsel, M. ( 1997; ). Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 3, 42–47.[CrossRef]
    [Google Scholar]
  5. Bourinbaiar, A. S. & Nagorny, R. ( 1993; ). Human immunodeficiency virus type 1 infection of choriocarcinoma-derived trophoblasts. Acta Virol 37, 21–28.
    [Google Scholar]
  6. Bryson, Y. J., Luzuriaga, K., Sullivan, J. L. & Wara, D. W. ( 1992; ). Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 327, 1246–1247.[CrossRef]
    [Google Scholar]
  7. Connor, E. M., Sperling, R. S., Gelber, R. & 17 other authors ( 1994; ). Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331, 1173–1180.[CrossRef]
    [Google Scholar]
  8. Coulomb-L'Hermine, A., Emilie, D., Durand-Gasselin, I., Galanaud, P. & Chaouat, G. ( 2000; ). SDF-1 production by placental cells: a potential mechanism of inhibition of mother-to-fetus HIV transmission. AIDS Res Hum Retroviruses 16, 1097–1098.[CrossRef]
    [Google Scholar]
  9. Damsky, C. H., Fitzgerald, M. L. & Fisher, S. J. ( 1992; ). Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 89, 210–222.[CrossRef]
    [Google Scholar]
  10. Descamps, L., Cecchelli, R. & Torpier, G. ( 1997; ). Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J Neuroimmunol 74, 173–184.[CrossRef]
    [Google Scholar]
  11. Dezube, B. J., Ahlers, C. M., Lawrence, J. P., Teng, E. I., Silberman, S. L., Pardee, A. B. & Finberg, R. W. ( 1997; ). Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells. J Acquir Immune Defic Syndr Hum Retrovirol 14, 13–17.[CrossRef]
    [Google Scholar]
  12. Doms, R. W. & Peiper, S. C. ( 1997; ). Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235, 179–190.[CrossRef]
    [Google Scholar]
  13. Douglas, G. C. & Thirkill, T. L. ( 2001; ). Chemokine receptor expression by human syncytiotrophoblast – a review. Placenta 22 Suppl. A, S24–S28.[CrossRef]
    [Google Scholar]
  14. Douglas, G. C., Fry, G. N., Thirkill, T., Holmes, E., Hakim, H., Jennings, M. & King, B. F. ( 1991; ). Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Res Hum Retroviruses 7, 735–740.[CrossRef]
    [Google Scholar]
  15. Douglas, G. C., Fazely, F. & Hu, J. J. ( 1998; ). Transmission of HIV to the placenta, fetus and mother and implications of gametic infection. J Reprod Immunol 41, 321–329.[CrossRef]
    [Google Scholar]
  16. Douglas, G. C., Thirkill, T. L. & LaSalle, J. ( 2001; ). Automated quantitation of cell-mediated HIV type 1 infection of human syncytiotrophoblast cells by fluorescence in situ hybridization and laser scanning cytometry. AIDS Res Hum Retroviruses 17, 507–516.[CrossRef]
    [Google Scholar]
  17. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S. & Rabson, A. B. ( 1989; ). Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc Natl Acad Sci U S A 86, 5974–5978.[CrossRef]
    [Google Scholar]
  18. Elovitz, M. A., Wang, Z., Chien, E. K., Rychlik, D. F. & Phillippe, M. ( 2003; ). A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 163, 2103–2111.[CrossRef]
    [Google Scholar]
  19. Garcia, P. M., Kalish, L. A., Pitt, J. & 9 other authors ( 1999; ). Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 341, 394–402.[CrossRef]
    [Google Scholar]
  20. Goldenberg, R. L., Vermund, S. H., Goepfert, A. R. & Andrews, W. W. ( 1998; ). Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission? Lancet 352, 1927–1930.[CrossRef]
    [Google Scholar]
  21. Goldenberg, R. L., Hauth, J. C. & Andrews, W. W. ( 2000; ). Intrauterine infection and preterm delivery. N Engl J Med 342, 1500–1507.[CrossRef]
    [Google Scholar]
  22. Gucer, F., Balkanli-Kaplan, P., Yuksel, M., Yuce, M. A., Ture, M. & Yardim, T. ( 2001; ). Maternal serum tumor necrosis factor-alpha in patients with preterm labor. J Reprod Med 46, 232–236.
    [Google Scholar]
  23. Hemmings, D. G., Lowen, B., Sherburne, R., Sawicki, G. & Guilbert, L. J. ( 2001; ). Villous trophoblasts cultured on semi-permeable membranes form an effective barrier to the passage of high and low molecular weight particles. Placenta 22, 70–79.[CrossRef]
    [Google Scholar]
  24. Hershow, R. C., Riester, K. A., Lew, J. & 9 other authors ( 1997; ). Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. Women and Infants Transmission Study. J Infect Dis 176, 414–420.[CrossRef]
    [Google Scholar]
  25. International Perinatal HIV Group ( 1999; ). The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 – a meta-analysis of 15 prospective cohort studies. N Engl J Med 340, 977–987.[CrossRef]
    [Google Scholar]
  26. Ishii, M., Hayakawa, S., Suzuki, M. K., Yoshino, N., Honda, M., Nishinarita, S., Chishima, F., Nagaishi, M. & Satoh, K. ( 2000; ). Expression of functional chemokine receptors of human placental cells. Am J Reprod Immunol 44, 365–373.[CrossRef]
    [Google Scholar]
  27. Kanmogne, G. D., Grammas, P. & Kennedy, R. C. ( 2000; ). Analysis of human endothelial cells and cortical neurons for susceptibility to HIV-1 infection and co-receptor expression. J Neurovirol 6, 519–528.[CrossRef]
    [Google Scholar]
  28. Kanmogne, G. D., Kennedy, R. C. & Grammas, P. ( 2001; ). Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein. AIDS Res Hum Retroviruses 17, 45–53.[CrossRef]
    [Google Scholar]
  29. Kilani, R. T., Chang, L. J., Garcia-Lloret, M. I., Hemmings, D., Winkler-Lowen, B. & Guilbert, L. J. ( 1997; ). Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection. J Virol 71, 6359–6372.
    [Google Scholar]
  30. Kliman, H. J., Nestler, J. E., Sermasi, E., Sanger, J. M. & Strauss, J. F., III ( 1986; ). Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118, 1567–1582.[CrossRef]
    [Google Scholar]
  31. Lagaye, S., Derrien, M., Menu, E. & 7 other authors ( 2001; ). Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol 75, 4780–4791.[CrossRef]
    [Google Scholar]
  32. Landesman, S. H., Kalish, L. A., Burns, D. N. & 7 other authors (1996; ). Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med 334, 1617–1623.[CrossRef]
    [Google Scholar]
  33. Loose, L. D., Sipe, J. D., Kirby, D. S. & 7 other authors ( 1993; ). Reduction of acute-phase proteins with tenidap sodium, a cytokine-modulating anti-rheumatic drug. Br J Rheumatol 32 Suppl 3, 19–25.[CrossRef]
    [Google Scholar]
  34. Mandelbrot, L., Mayaux, M. J., Bongain, A. & 7 other authors ( 1996; ). Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group. Am J Obstet Gynecol 175, 661–667.[CrossRef]
    [Google Scholar]
  35. Mano, H. & Chermann, J. C. ( 1991; ). Fetal human immunodeficiency virus type 1 infection of different organs in the second trimester. AIDS Res Hum Retroviruses 7, 83–88.
    [Google Scholar]
  36. Matsumoto, H. & Fujii, A. ( 2002; ). Tenidap, an anti-inflammatory agent, inhibits DNA and collagen syntheses, depresses cell proliferation, and lowers intracellular pH in cultured human gingival fibroblasts. J Pharmacol Exp Ther 300, 668–672.[CrossRef]
    [Google Scholar]
  37. Maymon, E., Ghezzi, F., Edwin, S. S., Mazor, M., Yoon, B. H., Gomez, R. & Romero, R. ( 1999; ). The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 181, 1142–1148.[CrossRef]
    [Google Scholar]
  38. McGann, K. A., Collman, R., Kolson, D. L., Gonzalez-Scarano, F., Coukos, G., Coutifaris, C., Strauss, J. F. & Nathanson, N. ( 1994; ). Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis 169, 746–753.[CrossRef]
    [Google Scholar]
  39. McNiff, P., Svensson, L., Pazoles, C. J. & Gabel, C. A. ( 1994; ). Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. I. Mechanism and evidence of functional significance. J Immunol 153, 2180–2193.
    [Google Scholar]
  40. Moussa, M., Mognetti, B., Dubanchet, S., Menu, E., Roques, P., Gras, G., Dormont, D., Barre-Sinoussi, F. & Chaouat, G. ( 1999; ). Vertical transmission of HIV: parameters which might affect infection of placental trophoblasts by HIV-1: a review. Biomed Group on the Study of in Utero Transmission of HIV 1. Am J Reprod Immunol 41, 312–319.[CrossRef]
    [Google Scholar]
  41. Palacios, I., Lopez-Armada, M. J., Hernandez, P., Sanchez-Pernaute, O., Gutierrez, S., Miguelez, R., Martinez, J., Egido, J. & Herrero-Beaumont, G. ( 1998; ). Tenidap decreases IL-8 and monocyte chemotactic peptide-1 (MCP-1) mRNA expression in the synovial tissue of rabbits with antigen arthritis and in cultured synovial cells. Clin Exp Immunol 111, 588–596.[CrossRef]
    [Google Scholar]
  42. Parry, S., Holder, J. & Strauss, J. F., III ( 1997; ). Mechanisms of trophoblast-virus interaction. J Reprod Immunol 37, 25–34.[CrossRef]
    [Google Scholar]
  43. Parry, S., Holder, J., Halterman, M. W., Weitzman, M. D., Davis, A. R., Federoff, H. & Strauss, J. F., III ( 1998; ). Transduction of human trophoblastic cells by replication-deficient recombinant viral vectors. Promoting cellular differentiation affects virus entry. Am J Pathol 152, 1521–1529.
    [Google Scholar]
  44. Patterson, B. K., Behbahani, H., Kabat, W. J. & 7 other authors ( 2001; ). Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest 107, 287–294.[CrossRef]
    [Google Scholar]
  45. Phillips, D. M. & Tan, X. ( 1992; ). HIV-1 infection of the trophoblast cell line BeWo: a study of virus uptake. AIDS Res Hum Retroviruses 8, 1683–1691.[CrossRef]
    [Google Scholar]
  46. Rasmussen, C. A., Pace, J. L., Banerjee, S., Phillips, T. A. & Hunt, J. S. ( 1999; ). Trophoblastic cell lines generated from tumour necrosis factor receptor-deficient mice reveal specific functions for the two tumour necrosis factor receptors. Placenta 20, 213–222.[CrossRef]
    [Google Scholar]
  47. Ringler, G. E. & Strauss, J. F., III ( 1990; ). In vitro systems for the study of human placental endocrine function. Endocr Rev 11, 105–123.[CrossRef]
    [Google Scholar]
  48. Sheikh, A. U., Polliotti, B. M. & Miller, R. K. ( 2000; ). Human immunodeficiency virus infection: in situ polymerase chain reaction localization in human placentas after in utero and in vitro infection. Am J Obstet Gynecol 182, 207–213.[CrossRef]
    [Google Scholar]
  49. Sipe, J. D., Bartle, L. M. & Loose, L. D. ( 1992; ). Modification of proinflammatory cytokine production by the antirheumatic agents tenidap and naproxen. A possible correlate with clinical acute phase response. J Immunol 148, 480–484.
    [Google Scholar]
  50. Steinborn, A., Gunes, H., Roddiger, S. & Halberstadt, E. ( 1996; ). Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection. Obstet Gynecol 88, 534–539.[CrossRef]
    [Google Scholar]
  51. Tscherning-Casper, C., Papadogiannakis, N., Anvret, M., Stolpe, L., Lindgren, S., Bohlin, A. B., Albert, J. & Fenyo, E. M. ( 1999; ). The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol 73, 9673–9678.
    [Google Scholar]
  52. Vidricaire, G., Imbeault, M. & Tremblay, M. J. ( 2004; ). Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts. J Virol 78, 11904–11915.[CrossRef]
    [Google Scholar]
  53. Wabwire-Mangen, F., Gray, R. H., Mmiro, F. A., Ndugwa, C., Abramowsky, C., Wabinga, H., Whalen, C., Li, C. & Saah, A. J. ( 1999; ). Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda. J Acquir Immune Defic Syndr 22, 379–385.[CrossRef]
    [Google Scholar]
  54. Yang, L., Lindholm, K., Konishi, Y., Li, R. & Shen, Y. ( 2002; ). Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. J Neurosci 22, 3025–3032.
    [Google Scholar]
  55. Zachar, V., Fink, T., Koppelhus, U. & Ebbesen, P. ( 2002; ). Role of placental cytokines in transcriptional modulation of HIV type 1 in the isolated villous trophoblast. AIDS Res Hum Retroviruses 18, 839–847.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81071-0
Loading
/content/journal/jgv/10.1099/vir.0.81071-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error